After treating with different working concentrations of ECD, the mRNA expression levels of MAPKs, PPARs, and STATs in the CRC cell lines significantly decreased, while those of TP53 increased compared to the respective control groups. The gene discussed is TP53; the disease is colorectal carcinoma.